Sign inJoin waitlistJoin the waitlist

Ryotaro Nakamura

Director, Center for Stem Cell Transplantation · City of Hope National Medical Center

Credentials: · · · · ·

History

Center for Stem Cell Transplantation · City of Hope National Medical Center
Present
Department of Hematology & Hematopoietic Cell Transplantation · City of Hope National Medical Center
Present
HCT Center of City of Hope Hematologic Malignancies Institute · City of Hope National Medical Center
Present

Hematology and Medical Oncology
National Institutes of Health
1998–2001
Internal Medicine
Thomas Jefferson University Hospital
1995–1998
Kumamoto University Hospital
1991–1993
KUMAMOTO UNIV, KUMAMOTO, KUMAMOTO
1987–1991

Research

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
New England Journal of Medicine · 2006 · 994 citations
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Blood · 2015 · 549 citations
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
Blood · 2017 · 415 citations

Stephen Forman
141 papers
VP
Vinod Pullarkat
88 papers
Monzr Al Malki
86 papers · 2 as a fellow
AS
Amandeep Salhotra
82 papers
AS
Anthony Stein
82 papers
Guido Marcucci
81 papers
Haris Ali
79 papers
Ibrahim Aldoss
78 papers
KS
Karamjeet Sandhu
59 papers
Ahmed Aribi
56 papers
Andrew Artz
46 papers
SA
Shukaib Arslan
41 papers · 3 as a fellow

Grants

BMT CTN Core - City of Hope National Medical Center
National Heart, Lung, and Blood Institute · UG1
Contact PI · $2.2M · Beckman Research Institute/City of Hope
2001–2031
CMV-Specific CD19 CAR T Cells Amplified in vivo Using CMV Triplex Vaccine for B-NHL
National Cancer Institute · R01
PI · $1.5M · Beckman Research Institute/City of Hope
2024–2029
Blood and Marrow Transplant Clinical Research Network
National Heart, Lung, and Blood Institute · U10
Contact PI · $869.4K · Beckman Research Institute/City of Hope
2001–2017

Clinical trials

The High Fiber Program to Increase Fiber Intake Among Patients Undergoing Allogeneic Hematopoietic Cell Transplant
Principal investigator · Not yet recruiting
City of Hope Medical Center
2027–2028
BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
Principal investigator · Not yet recruiting · Phase 1
City of Hope Medical Center
2026–2027
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
Principal investigator · Not yet recruiting
City of Hope Medical Center
2026–2030
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Principal investigator · Recruiting · Phase 1
City of Hope Medical Center
2026–2029